Trial Profile
Comparison of carbohydrate metabolism during the night and at hypoglycemia in type-2 diabetic patients either on glargine [insulin glargine] or NPH insulin [insulin suspension isophane]
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Jan 2009
Price :
$35
*
At a glance
- Drugs Insulin glargine (Primary) ; Insulin suspension isophane
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 09 May 2007 New trial record.